Posts
-
Global leaders unite to ensure everyone everywhere can access new vaccines, tests and treatments for COVID-19
8 May, 2020Unprecedented gathering of heads of government, institutions and industry cements commitment to accelerate development and delivery for all populations
Click here for reference
-
Vitamin D levels appear to play role in COVID-19 mortality rates
8 May, 2020After studying global data from the novel coronavirus (COVID-19) pandemic, researchers have discovered a strong correlation between severe vitamin D deficiency and mortality rates.
Led by Northwestern University, the research team conducted a statistical analysis of data from hospitals and clinics across China, France, Germany, Italy, Iran, South Korea, Spain, Switzerland, the United Kingdom (UK) and the United States.
The researchers noted that patients from countries with high... -
Mystery Inflammatory Syndrome In Kids And Teens Likely Linked To COVID-19
8 May, 2020
Sixty-four children and teens in New York State are suspected of having a mysterious inflammatory syndrome that is believed to be linked to COVID-19, the New York Department of Health said in an alert issued Wednesday. A growing number of similar cases — including at least one death — have been reported in other parts of the U.S. and Europe, though the phenomenon is still not well-understood.
Pediatricians say parents should not panic; the condition remains extremely ra... -
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
8 May, 2020Mortality of patients with coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), and systemic inflammation is high. In areas of pandemic outbreak, the number of patients can exceed maximum capacity of intensive care units (ICUs), and, thus, these individuals often receive non-invasive ventilation outside of the ICU. Effective treatments for this population are needed urgently. Anakinra is a recombinant interleukin-1 receptor antagonist that might be beneficial i... -
Beat COVID-19 through innovation
8 May, 2020As coronavirus disease 2019 (COVID-19) has spread, public health and economic well-being are increasingly in conflict. Governments are prioritizing public health, but the current solution—social isolation—is costly as commerce remains shut down. Restarting economies could rekindle the pandemic and cause even worse human suffering. Innovation can help societies escape the untenable choice between public and economic health. The world needs effective vaccines, therapies, or other solutions. But... -
From Loss Of Smell To 'COVID Toes': What Experts Are Learning About Symptoms
8 May, 2020
When the coronavirus pandemic first emerged, public health officials told the world to watch out for its telltale symptoms: fever, dry cough and shortness of breath. But as the virus has spread across the globe, researchers have developed a more nuanced picture of how symptoms of infection can manifest themselves, especially in milder cases.
We're getting a "better understanding of how these symptoms express in the general population and not necessarily in hospitalized patients," w... -
Blood thinners may improve survival among hospitalized COVID-19 patients
8 May, 2020
Research could change standard of care protocols to prevent clotting associated with coronavirus.
Treating hospitalized COVID-19 patients with anticoagulants -- blood thinners that slow down clotting -- may improve their chances of survival, researchers from the Mount Sinai COVID Informatics Center report. The study, published in the May 6 issue of the Journal of the American College of Cardiology, could provide new insight on how to treat and manage coronavirus patients once they ... -
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
8 May, 2020Hydroxychloroquine has been widely administered to patients with Covid-19 without robust evidence supporting its use.
METHODS We examined the association between hydroxychloroquine use and intubation or death at a large medical center in New York City. Data were obtained regarding consecutive patients hospitalized with Covid-19, excluding those who were intubated, died, or discharged within 24 hours after presentation to the emergency department (study baseline). The primary end point w... -
The groundbreaking way to search lungs for signs of Covid-19
7 May, 2020When Covid-19 was at its height in China, doctors in the city of Wuhan were able to use artificial intelligence (AI) algorithms to scan the lungs of thousands of patients
The algorithm in question, developed by Axial AI, analyses CT imagery in seconds. It declares, for example, whether a patient has a high risk of viral pneumonia from coronavirus or not. A consortium of firms developed the AI in response to the coronavirus outbreak. They say it can show whether a patient's lung... -
COVID‐19: Impact on Colorectal Surgery
7 May, 2020AbstractThe rapid spread of the COVID‐19 pandemic created unprecedented challenges for the medical and surgical healthcare systems. With the ongoing need for urgent and emergency colorectal surgery including colorectal cancer surgeries, several questions pertaining to the operating room (OR) utilization and techniques needed to be rapidly addressed. Although patient safety is of paramount importance, caregiver safety is also a critical consideration. During the COVID‐19 pandemic, additional p... -
Skin protection for health care workers during COVID-19 epidemic must not be ignored
7 May, 2020Abstract
Since first reported in 2019, pneumonia associated with 2019 novel coronavirus disease (COVID‐19) has rapidly developed into an outbreak across the world. Number of the patients of all age groups has increased significantly. In order to curb the spread of the epidemic, thousands of health care workers (HCWs) have joined the front line of the fight against this highly contagious disease. When taking care of patients with COVID‐19 pneumonia, HCWs must first protect themselves by per... -
The immune system of children: the key to understanding SARS-CoV-2 susceptibility?
7 May, 2020Adults can be infected with different outcomes, from asymptomatic, mild, moderate to severe disease, and death. Children can also be infected by SARS-CoV-2, but most paediatric cases with laboratory-confirmed SARS-CoV-2 infection are mild; severe COVID-19 disease in children is rare.Children are more vulnerable to other infections; thus, the important question arises—why are children less susceptible to COVID-19 disease compared with adults? So far, there is no evidence of a lower degree of e...